| Application number | Title of the application | Filing Date | Status |
|---|
| 09/708222 | 46867 transferase family members and uses therefor | Nov 6, 2000 | Abandoned |
Array
(
[id] => 1229123
[patent_doc_number] => 06696546
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-02-24
[patent_title] => 'Peptide that kills growing but not stationary cells'
[patent_app_type] => B1
[patent_app_number] => 09/707263
[patent_app_country] => US
[patent_app_date] => 2000-11-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 24
[patent_no_of_words] => 9957
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/696/06696546.pdf
[firstpage_image] =>[orig_patent_app_number] => 09707263
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/707263 | Peptide that kills growing but not stationary cells | Nov 5, 2000 | Issued |
| 09/702257 | Novel methods of diagnosing breast cancer, compositions, and methods of screening for breast cancer modulators | Oct 29, 2000 | Abandoned |
| 09/380983 | Radiolabelled somatostatin receptor ligands for diagnosis and therapy | Oct 29, 2000 | Abandoned |
Array
(
[id] => 1091790
[patent_doc_number] => 06824780
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-11-30
[patent_title] => 'Anti-tumor antibody compositions and methods of use'
[patent_app_type] => B1
[patent_app_number] => 09/698705
[patent_app_country] => US
[patent_app_date] => 2000-10-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 33
[patent_no_of_words] => 43390
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/824/06824780.pdf
[firstpage_image] =>[orig_patent_app_number] => 09698705
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/698705 | Anti-tumor antibody compositions and methods of use | Oct 26, 2000 | Issued |
| 09/694538 | Cadherin peptides for drug delivery and inhibittion of tumor metastasis/invasion | Oct 22, 2000 | Abandoned |
Array
(
[id] => 1323363
[patent_doc_number] => 06602674
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-08-05
[patent_title] => 'Uses of antileukoprotease in carcinoma'
[patent_app_type] => B1
[patent_app_number] => 09/692820
[patent_app_country] => US
[patent_app_date] => 2000-10-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 10
[patent_no_of_words] => 6669
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/602/06602674.pdf
[firstpage_image] =>[orig_patent_app_number] => 09692820
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/692820 | Uses of antileukoprotease in carcinoma | Oct 17, 2000 | Issued |
| 09/623035 | Tumor associated antigen 791tgp72 | Oct 11, 2000 | Abandoned |
| 09/600981 | Inhibition of dna modulation caused by mutated p53 | Oct 3, 2000 | Abandoned |
| 09/679460 | Endozepine-like polypeptides and polynucleotides encoding same | Oct 3, 2000 | Abandoned |
Array
(
[id] => 865139
[patent_doc_number] => 07368545
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2008-05-06
[patent_title] => 'PCA3 messenger RNA species in benign and malignant prostate tissues'
[patent_app_type] => utility
[patent_app_number] => 09/675650
[patent_app_country] => US
[patent_app_date] => 2000-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 5
[patent_no_of_words] => 13320
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/368/07368545.pdf
[firstpage_image] =>[orig_patent_app_number] => 09675650
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/675650 | PCA3 messenger RNA species in benign and malignant prostate tissues | Sep 28, 2000 | Issued |
| 09/646541 | Use of dipeptidyl peptidase (DPP4) for suppressing the malignant phenotype of cancer cells | Sep 17, 2000 | Abandoned |
Array
(
[id] => 756622
[patent_doc_number] => 07014848
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2006-03-21
[patent_title] => 'Enhanced anti-tumor immunity'
[patent_app_type] => utility
[patent_app_number] => 09/663072
[patent_app_country] => US
[patent_app_date] => 2000-09-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 12697
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/014/07014848.pdf
[firstpage_image] =>[orig_patent_app_number] => 09663072
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/663072 | Enhanced anti-tumor immunity | Sep 14, 2000 | Issued |
Array
(
[id] => 968405
[patent_doc_number] => 06939679
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2005-09-06
[patent_title] => 'NADE binding proteins'
[patent_app_type] => utility
[patent_app_number] => 09/661305
[patent_app_country] => US
[patent_app_date] => 2000-09-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7356
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 132
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/939/06939679.pdf
[firstpage_image] =>[orig_patent_app_number] => 09661305
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/661305 | NADE binding proteins | Sep 12, 2000 | Issued |
Array
(
[id] => 1196432
[patent_doc_number] => 06727080
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-04-27
[patent_title] => 'Gene encoding labyrinthin, a marker for cancer'
[patent_app_type] => B1
[patent_app_number] => 09/659521
[patent_app_country] => US
[patent_app_date] => 2000-09-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 9504
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/727/06727080.pdf
[firstpage_image] =>[orig_patent_app_number] => 09659521
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/659521 | Gene encoding labyrinthin, a marker for cancer | Sep 11, 2000 | Issued |
Array
(
[id] => 1046829
[patent_doc_number] => 06864224
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2005-03-08
[patent_title] => 'Kinase inhibitors and methods of use in screening assays and modulation of cell proliferation and growth'
[patent_app_type] => utility
[patent_app_number] => 09/654281
[patent_app_country] => US
[patent_app_date] => 2000-09-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 13
[patent_no_of_words] => 25542
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/864/06864224.pdf
[firstpage_image] =>[orig_patent_app_number] => 09654281
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/654281 | Kinase inhibitors and methods of use in screening assays and modulation of cell proliferation and growth | Aug 31, 2000 | Issued |
| 09/653464 | Methods and compositions of a novel serine protease | Aug 30, 2000 | Abandoned |
Array
(
[id] => 793106
[patent_doc_number] => 06982151
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2006-01-03
[patent_title] => 'Design of novel assays based on the newly found role of dystroglycan and alpha-dystroglycan proteolysis in tumor cell growth'
[patent_app_type] => utility
[patent_app_number] => 09/652493
[patent_app_country] => US
[patent_app_date] => 2000-08-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 12
[patent_no_of_words] => 6275
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/982/06982151.pdf
[firstpage_image] =>[orig_patent_app_number] => 09652493
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/652493 | Design of novel assays based on the newly found role of dystroglycan and alpha-dystroglycan proteolysis in tumor cell growth | Aug 30, 2000 | Issued |
Array
(
[id] => 772768
[patent_doc_number] => 07001600
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2006-02-21
[patent_title] => 'Identification of TRP-2 as a human tumor antigen recognized by cytotoxic T lymphocytes'
[patent_app_type] => utility
[patent_app_number] => 09/651210
[patent_app_country] => US
[patent_app_date] => 2000-08-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 12685
[patent_no_of_claims] => 74
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/001/07001600.pdf
[firstpage_image] =>[orig_patent_app_number] => 09651210
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/651210 | Identification of TRP-2 as a human tumor antigen recognized by cytotoxic T lymphocytes | Aug 29, 2000 | Issued |
Array
(
[id] => 551686
[patent_doc_number] => 07160677
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2007-01-09
[patent_title] => 'Transcription factor DP-1'
[patent_app_type] => utility
[patent_app_number] => 09/645572
[patent_app_country] => US
[patent_app_date] => 2000-08-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 31
[patent_no_of_words] => 15858
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 124
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/160/07160677.pdf
[firstpage_image] =>[orig_patent_app_number] => 09645572
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/645572 | Transcription factor DP-1 | Aug 24, 2000 | Issued |
